REG - Iconic Labs PLC - Announcement of the Completion of CVA

Iconic LabsAnnouncement

13/10/2023 11:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231013:nRSM0919Qa&default-theme=true

RNS Number : 0919Q  Iconic Labs PLC  13 October 2023

 

 

13 October 2023

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Announcement of the Completion of CVA

 

Iconic Labs PLC (LSE: ICON) is pleased to announce that the Creditors
Voluntary Arrangement ("CVA") has been completed and the relevant documents
have been filed at and accepted by Companies House.

 

Brad Taylor, Chief Executive Officer of Iconic Labs, commented:

 

"The successful completion of the CVA marks an important step towards Iconic
Labs' financial stability. Now that the CVA is discharged, Iconic Labs has
removed historic debts and is well positioned to progress with growth
opportunities and focus on its strategic goals.

 

"We look forward to updating shareholders and the market on our further
activity in due course."

 

- Ends -

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.

 

For any further information or enquiries please contact:

 

 Iconic Labs                            Tel: +44 (0) 7462 156238

 Brad Taylor, Chief Executive Officer   ir@iconiclabs.co.uk
 Novum Securities Limited               Tel: +44 (0) 20 7399 9400

 David Coffman / Daniel Harris
 Yellow Jersey PR                       Tel: +44 (0) 20 3004 9512

 Sarah Hollins                          iconic@yellowjerseypr.com

 Annabelle Wills

 Bessie Elliot

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ARINKNBNKBDDKKD